Also listed on Scpharmaceuticals Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 30, 2040 · Low confidence
20-year base term ends Jan 30, 2040
Jan 30, 2020
Jan 30, 2040
Dec 9, 2025
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 0 of 3 maintenance fees are paid so far. Confidence: Low. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 30, 2020, when application PCT/US2020/015799, the earliest non-provisional in its chain, was filed (this one was filed Jun 6, 2024); a parent in its chain could not be resolved (the next row) | Jan 30, 2040 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,497,755, US 11,559,535, US 11,571,434, US 11,998,555, US 12,048,709, US 12,491,193, US 12,491,194, US 12,491,195, US 12,491,196) | resolves to Jan 30, 2040, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Further caveats on record | The record names parents not resolved: 18150590, 17426765 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Jan 30, 2040 | Low confidence |
This family
| Application PCT/US2020/015799 | PCT application no patent term | no patent term |
| US 11,998,555 | In force Jan 2040 | Jan 2040 |
| US 11,497,755 | In force Jan 2040 | Jan 2040 |
| US 11,571,434 | In force Jan 2040 | Jan 2040 |
| US 11,559,535 | In force Jan 2040 | Jan 2040 |
| US 12,048,709 | In force Jan 2040 | Jan 2040 |
| US 12,491,193 | In force Jan 2040 | Jan 2040 |
| US 12,491,194 | In force Jan 2040 | Jan 2040 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 7, 2024 Reel 68211, frame 842 | Grossi, Alfredo; Kostraba, Britt; Luca Ogunleye, Olatokumbo O.; Terry, Shannon; Koppenhagen, Franciscus | Scpharmaceuticals Inc. | Assignment of Assignor's Interest |
| Aug 13, 2024 Reel 68261, frame 702 | Scpharmaceuticals Inc. | Perceptive Credit Holdings IV, LP | Security Interest |
| Oct 8, 2025 Reel 72511, frame 726 | Perceptive Credit Holdings IV, LP | Scpharmaceuticals Inc. | Release of Security Interest |
| Aug 5, 2026 Reel 75534, frame 309 | Scpharmaceuticals Inc. | MannKind Corporation | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 11,497,755, US 11,559,535, US 11,571,434, US 11,998,555, US 12,048,709, US 12,491,193, US 12,491,194, US 12,491,195, US 12,491,196, ends no earlier than this term, so it caps nothing.